You are viewing: India Long Read Sequencing Market analysis
Part of: Long Read Sequencing Market (Global)

The India Long Read Sequencing Market was valued at $13.4 Million in 2024 and projected to reach to $59.1 Million by 2029, representing a compound annual growth rate of 34.6%. India's long read sequencing market is poised for exceptional growth, expanding from $13.4 million in 2024 to $59.1 million by 2029.

India Long Read Sequencing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

India Long Read Sequencing Market Trends and Insights

  • This robust growth trajectory reflects India's increasing adoption of advanced genomic technologies across research institutions, diagnostic centers, and pharmaceutical companies.
  • India is positioning itself as a key hub for genomic research in Asia Pacific, driven by rising investments in healthcare infrastructure and growing demand for precision medicine applications. The long read sequencing market in India is benefiting from declining sequencing costs, expanding bioinformatics capabilities, and government initiatives supporting genomic research.
  • India's large patient population and prevalence of genetic disorders create substantial demand for advanced diagnostic tools.
  • By 2029, India is expected to capture significant market share within the Asia Pacific region, supported by increasing collaborations between Indian research institutions and global genomic leaders. India's competitive advantage lies in its cost-effective research capabilities and skilled workforce.
  • The market in India is transitioning from early adoption to mainstream integration of long read sequencing technologies across clinical and research settings, positioning the country as an emerging leader in genomic innovation..

Key Market Statistics

  • CAGR (2024-2029) 34.6% CAGR
  • Market Size, 2024 ~USD 13.4 Million
  • Forecast, 2029 ~USD 59.1 Million
  • Country India

India Long Read Sequencing Market Overview

Rapid Market Expansion :

India's long read sequencing market is growing at 34.6% CAGR, significantly outpacing global growth of 32.8%, driven by increasing genomic research initiatives and diagnostic adoption across the country.

Strong Investment in Research Infrastructure :

Major research institutions and diagnostic centers in India are increasingly adopting long read sequencing technologies, positioning the country as a critical hub for genomic research in the Asia-Pacific region.

Pharmaceutical Industry Growth :

Indian pharmaceutical companies are leveraging long read sequencing for drug discovery and development, creating significant demand for advanced genomic technologies and supporting market expansion.

Cost-Effective Solutions Driving Adoption :

India's competitive advantage in providing cost-effective genomic sequencing services is attracting both domestic and international research collaborations, accelerating market penetration.

India Long Read Sequencing Market Dynamics

  • This trajectory reflects the country's strategic focus on genomic research infrastructure development and increasing healthcare digitalization.
  • Government initiatives supporting precision medicine and biotechnology innovation are creating favorable conditions for market expansion. The Indian market benefits from a large pool of skilled researchers, cost-competitive services, and growing collaborations with global genomic research organizations.
  • Diagnostic centers and pharmaceutical companies are increasingly investing in long read sequencing capabilities to enhance disease detection and drug development processes.
  • This momentum positions India as a key regional player in genomic technologies..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • India's long read sequencing market is projected to grow from $13.4M in 2024 to $59.1M by 2029, representing a 34.6% CAGR.
    • India is emerging as a cost-effective hub for genomic research, attracting international collaborations and investments in sequencing infrastructure.
    • Rising prevalence of genetic disorders and government support for precision medicine initiatives are driving market expansion in India.
    • India's skilled bioinformatics workforce and declining technology costs position the country for accelerated adoption of long read sequencing across clinical and research applications.

    Long Read Sequencing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment DATA ANALYSIS (Workflow)
    Forecast Period 2024-2029
    Growth Rate CAGR of 32.8% from 2024 to 2029
    Largest Segment RESEARCH USAGE (Usage)
    Market Size Base Year (Billions) ~USD 0.76 (2024)
    Revenue Forecast (Billions) ~USD 3.13 (2029)
    Segments Covered Offering, Technology, Workflow, Application, Usage, End User

    India Long Read Sequencing Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Offering

    • Consumables
    • Instruments
    • Services

    By Technology

    • Nanopore Sequencing
    • Single-Molecule Real-Time Sequencing
    • Synthetic Long-Read Sequencing

    By Workflow

    • Data Analysis
    • Sample Preparation
    • Sequencing

    By Application

    • Epigenetics
    • Metagenomics
    • Other Applications
    • Targeted Sequencing
    • Whole-Exome Sequencing
    • Whole-Genome Sequencing

    By Usage

    • Clinical Usage
    • Research Usage

    By End User

    • Academic & Research Institute
    • Academic & Research Institutes
    • Hospitals, Clinics & Diagnostic
    • Hospitals, Clinics, And Diagnostic Labs
    • Other End User
    • Other End Users
    • Pharmaceutical & Biotechnologies Companies
    • Pharmaceutical & Biotechnology Companies
    • Pharmaceutical & Biotechnology Companies Labs

    INDIA: LONG-READ SEQUENCING MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    ACADEMIC & RESEARCH INSTITUTE6.89.211.915.520.627.637.352.334.5
    HOSPITALS, CLINICS & DIAGNOSTIC2.12.83.64.86.48.611.616.435.3
    OTHER END USER0.60.811.21.51.92.3324.8
    PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES LABS3.24.35.67.39.612.917.424.434.2
    TOTAL12.717.222.128.838.150.968.69634.2

    Target Audience

    • Pharmaceutical & Biotech Companies : Need India-specific market data to assess opportunities for drug discovery investments, establish R&D centers, and leverage cost-effective genomic research capabilities in the country.
    • Diagnostic Service Providers : Require detailed market insights to understand adoption rates, competitive landscape, and growth potential for expanding long read sequencing diagnostic services across Indian healthcare facilities.
    • Medical Device & Equipment Manufacturers : Need India market analysis to identify demand for sequencing instruments, plan distribution strategies, and understand purchasing patterns among research institutions and diagnostic labs.
    • Healthcare Investors & Venture Capitalists : Seek India-focused market data to evaluate investment opportunities in genomic startups, diagnostic platforms, and precision medicine companies operating in this high-growth market.
    • Government & Policy Makers : Require market intelligence to develop genomic research policies, allocate healthcare budgets, and create regulatory frameworks supporting India's position as a regional genomics leader.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise market valuation ($13.4M in 2024) and verified 5-year forecast ($59.1M by 2029) specific to India, enabling accurate business planning and investment decisions in the region.
    • Competitive Positioning Strategy : Understand India's 34.6% CAGR advantage over global growth rates to identify market entry opportunities and competitive advantages in this high-growth emerging market.
    • Stakeholder-Specific Insights : Access detailed analysis of India's research institutions, diagnostic centers, and pharmaceutical sector adoption patterns to tailor products and services for maximum market penetration.
    • Regional Hub Opportunity Assessment : Evaluate India's positioning as a key Asia-Pacific genomic research hub to identify partnership opportunities, collaboration potential, and regional expansion strategies.
    • Investment & Funding Decisions : Make informed capital allocation decisions with India-specific market data, growth drivers, and infrastructure development trends supporting long-term business viability.

    Frequently asked questions

    What is the current size of India's long read sequencing market?

    India's long read sequencing market was valued at $13.4 million in 2024 and is expected to grow to $59.1 million by 2029.

    What is the projected growth rate for long read sequencing in India?

    India's long read sequencing market is projected to grow at a compound annual growth rate (CAGR) of 34.6% from 2024 to 2029.

    What factors are driving growth in India's long read sequencing market?

    Key drivers include declining sequencing costs, government initiatives supporting genomic research, India's large patient population, rising prevalence of genetic disorders, and increasing investments in healthcare infrastructure.

    Which sectors are adopting long read sequencing technology in India?

    Long read sequencing is being adopted across research institutions, diagnostic centers, pharmaceutical companies, and academic medical centers in India for precision medicine and genomic research applications.

    How does India's long read sequencing market compare regionally?

    India is emerging as a key growth market within Asia Pacific, leveraging cost-effective research capabilities and skilled workforce to capture significant market share in the long read sequencing sector.

    RESEARCH METHODOLOGY

    This study on the long-read sequencing market employed secondary sources, directories, and databases to gather pertinent information. To gather and validate important qualitative and quantitative data and evaluate market growth prospects, in-depth interviews were conducted with many primary respondents including key industry participants, subject-matter experts (SMEs), C-level executives from key market players, and industry consultants. After estimating the long-read sequencing market using several research strategies, the size of the final market was obtained by triangulating data from primary research.

    Secondary Research

    The secondary sources referred to for this research study include publications from government sources. These include Nucleic Acids Research, Genome Biology, Nature Reviews Genetics, Nature Methods, Genome Research, International Journal of Genomics, National Human Genome Research Institute (NHGRI), International Chromosome and Genome Society (ICGS), Genome Canada, European Society of Human Genetics (ESHG), Genomics England, Genome British Columbia, Beijing Institute of Genomics, Centre for Cellular & Molecular Biology (CCMB), São Paulo Research Foundation (FAPESP), National Cancer Institute (NCI), European Medicines Agency (EMA), Biotechnology and Biological Sciences Research Council (BBSRC), Organisation for Economic Co-operation and Development (OECD), Population Health Research Institute (PHRI),  PubMed, World Bank, and the World Health Organization (WHO), among others. Secondary sources also included corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global long-read sequencing market, which was validated through primary research.

    Primary Research

    Extensive primary research was conducted after acquiring basic knowledge about the global long-read sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from the supply side, such as C-level and D-level executives, operational managers, marketing & sales managers of key manufacturers, distributors, and channel partners of companies providing long-read sequencing; experts from the demand side, such as personnel from academic & research institutes, hospitals, clinics and diagnostic labs, pharmaceutical & biopharmaceutical industries. These interviews were conducted across six major regions, including North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

    The following is a breakdown of the primary respondents:

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the long-read sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Bottom-up Approach

    • The key players in the industry and market have been identified through extensive secondary research.
    • The revenues generated from the long-read sequencing market business of leading players have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Top-down Approach

    After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

    Long Read Sequencing Market Size, and Share

    Data Triangulation

    To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Long-read sequencing is a type of nucleic acid sequencing that produces genomic data by generating individual reads from single molecules, generally ranging in size from 700 to over 20,000 bases. These fragments are typically derived from "native" molecules, which are directly extracted from biological samples for analysis. The long-read sequencing market encompasses the consumables, instruments, services, and technology associated with long-read sequencing. The long-read sequencing market is defined as solutions including instruments/systems, consumables (kits, reagents, flow cells), and services for long-read sample preparation, sequencing, and data analysis. Long-read software solutions are often provided alongside the instrument/system/platform, hence the software solutions are considered within the instrument segment scope. Other standalone software solutions are provided as data analysis services and are considered within the services segment scope.

    Stakeholders

    • Academic & Research Institutes
    • Software & Bioinformatics Companies
    • Healthcare & Clinical Laboratories
    • Long-Read Sequencing Technology Vendors
    • Contract Research Organizations (CROs)
    • Market Research and Consulting Firms
    • Pharmaceutical & Biotechnology Companies
    • Regulatory Agencies
    • Venture Capitalists
    • Government Organizations
    • Industry Associations and Professional Societies

    Report Objectives

    • To define, describe, and forecast the long-read sequencing market based on offerings, technology, workflow, application, usage, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall long-read sequencing market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
    • To profile the key players in the global long-read sequencing market and comprehensively analyze their instruments, consumables, and services portfolios, market positions, and core competencies
    • To track and analyze competitive developments such as product & service launches, expansions, agreements, and collaborations in the long-read sequencing market
    • To benchmark players within the long-read sequencing market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and service strategy

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Geographical Analysis

    • Further breakdown of the Rest of Europe Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Asia Pacific Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Latin America Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Middle East Long-Read Sequencing Market, by country

    Company Information

    • Detailed analysis and profiling of additional market players (up to five)

    Segment Analysis

    • Further breakdown of the other application and other end users area into subsegments
    • Cross-segment analysis

    Get the Full Long Read Sequencing Market Report

    Full forecast, segment splits, and company analysis for all Long Read Sequencing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status